Development of cladribine at Scripps for hairy cell leukemia and current results

Leukemia and Lymphoma

Volumn 52, Issue SUPPL. 2, 2011, Pages 29-33

  Torrey, Melissa L ^a   Sigal, Darren S ^a   Saven, Alan ^a,b  

^a SCRIPPS CLINIC   (United States)

^b Ida M and Cecil H Green Cancer Center   (United States)

Author keywords

Cladribine; hairy cell leukemia

Indexed keywords

ADENOSINE DEAMINASE; ALPHA INTERFERON; CLADRIBINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOTOXIN; IMMUNOTOXIN BL 22; PENTOSTATIN; RITUXIMAB; UNCLASSIFIED DRUG;

ADENOSINE DEAMINASE DEFICIENCY; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER REGRESSION; CANCER RELAPSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTINUOUS INFUSION; CYTOTOXICITY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; HAIRY CELL LEUKEMIA; HUMAN; INFECTION; LYMPHOCYTE; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; SPLENECTOMY; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

CLADRIBINE; HUMANS; LEUKEMIA, HAIRY CELL; NEOPLASM, RESIDUAL; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 79957458304     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.569621     Document Type: Article

References (18)

1. Else M, Dearden C, Matutes E, et al. Long-term follow up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 2009;145:733-740.
2. Saven A, Burian C, Koziol JA, et al. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998;92:1918-1926. (Pubitemid 28446680)
3. Sigal, D, Sharpe R, Burian C, Saven A. Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine. Blood 2010;115:1893-1896.
4. Saven A. Hairy cell leukemia. In: Lichtman MA, Kipps TJ, Kaushansky K, et al., editors. Williams Hematology. 7th ed. New York: McGraw-Hill; 2006. pp 1385-1393.
5. Carson DA, Wasson DB, Kaye J, et al. Deoxycytidine kinasemediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc Natl Acad Sci USA 1980;77:6865-6869. (Pubitemid 11219046)
6. Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet 1992;340:952-956.
7. Piro LD, Carrera CJ, Carson DA, et al. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2- chlorodeoxyadenosine. N Engl J Med 1990;322:1117-1121. (Pubitemid 20149529)
8. Goodman GR, Burian C, Koziol JA, et al. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21:891-896. (Pubitemid 46606450)
9. Dearden CE, Matutes, E, Hilditch BL, et al. Long-term followup of patients with hairy cell leukemia after treatment with pentostatin or cladribine. Br J Haematol 1999;106:515-519. (Pubitemid 29450680)
10. Wheaton S, Tallman MS, Hakimian D, et al. Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Blood 1996;87:1556-1560. (Pubitemid 26056921)
11. Ellison DJ, Sharpe RW, Robbins BA, et al. Immunomorphologic analysis of bone marrow biopsies after treatment with 2- chlorodeoxyadenosine for hairy cell leuekmia. Blood 1994;84:4310-4315.
12. Sigal D, Miller H, Schram E, Saven A. Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Blood 2010;116:2884-2896.
13. Huynh E, Sigal D, Saven A. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results. Leuk Lymphoma 2009;50(Suppl. 1):12-17.
14. Estey EH, Kurzrock R, Kantarjian HM, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 1992;79:882-887.
15. Juliusson G, Liliemark J. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-20-deoxyadenosine (CdA): relation to opportunistic infections. Blood 1992;79:888-894.
16. Hoffman MA, Janson D, Rose E, et al. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. J Clin Oncol 1997;15:1138-1442.
17. Tallman MS, Hakimian D, Rademaker AW, et al. Relapse of hairy cell leukemia after 2-chlorodeoxyadnenosine: long-term follow-up of the Northwestern University experience. Blood 1996;88:1954-1959. (Pubitemid 26307896)
18. Kraut EH, Grever MR, Bouroncle BA. Long-term follow-up of patients with hairy cell leukemia after treatment with 20- deoxycoformycin. Blood 1994;84:4061-4063.